2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease
Glenn N. Levine(American College of Cardiology), Sidney C. Smith(University of North Carolina at Chapel Hill), Eric Bates(Apple (Israel)), Christopher B. Granger(Clinical Research Institute), Roxana Mehran(Mount Sinai Hospital), Michael J. Mack(Baylor Jack and Jane Hamilton Heart and Vascular Hospital), Marc S. Sabatine(Brigham and Women's Hospital), Richard A. Lange(Association of Chartered Certified Accountants), Ralph G. Brindis, L. Kristin Newby(Duke University), Patrick T. O’Gara(Brigham and Women's Hospital), Laura Mauri(Brigham and Women's Hospital), John A. Bittl(Brigham and Women's Hospital), Peter K. Smith, Lee A. Fleisher(Living Beyond Breast Cancer), Stephan D. Fihn(University of Washington), Debabrata Mukherjee(Texas Tech University)
Cited by 1,638
Related Papers
Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery
|New England Journal of Medicine|2010|7.2k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients
|New England Journal of Medicine|2011|6.4k
Markers of Inflammation and Cardiovascular Disease
|Circulation|2003|6.3k
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k